Second-generation colon capsule endoscopy vs. colonoscopy in pediatric ulcerative colitis: a pilot study

Background and study aims: Second-generation colon capsule endoscopy (CCE-2) may overcome the invasiveness of colonoscopy in the evaluation of mucosal inflammation, especially in pediatric ulcerative colitis. The aim of this pilot study was to determine the diagnostic accuracy of CCE-2 in evaluating disease activity, using colonoscopy as a gold standard. Disease extent, tolerability, interobserver agreement, and safety were also evaluated.

Methods: A total of 30 consecutive pediatric patients with ulcerative colitis were prospectively enrolled (mean age 14.1 ± 3.2 years). Patients underwent CCE-2 followed by colonoscopy in the late afternoon or the following day. The blinded procedures were performed, and the diagnostic accuracy of CCE-2 to assess disease activity was determined using a modified Matts score, which classified patients as either normal (Matts score ≤ 6) or with active inflammation (Matts score > 6). Interobserver agreement was assessed using the kappa statistic.

Results: One patient was excluded from the analysis because they were unable to swallow the capsule, leaving 29 patients available for analysis. The sensitivity of CCE-2 for disease activity was 96 % (95 % confidence interval [CI] 79 – 99) and specificity was 100 % (95 %CI 61 – 100). The positive and negative predictive values of CCE-2 were 100 % (95 %CI 85 – 100) and 85 % (95 %CI 49 – 97), respectively. No serious adverse events were reported. CCE-2 had a higher overall tolerability than colonoscopy (P < 0.05). Interobserver agreement was excellent in all cases (κ > 0.86).

Conclusions: Using a modified Matts score, CCE-2 was accurate in evaluating significant mucosal inflammation in children with ulcerative colitis.

Trial registration:ClinicalTrials.gov – NCT01740349

^* These authors contributed equally to the study

• References

• 1 de Bie CI, Buderus S, Sandhu BK et al. and the EUROKIDS Porto IBD Working Group of ESPGHAN Diagnostic workup of pediatric inflammatory bowel disease patients in Europe: results of a 5-year audit of the EUROKIDS registry. J Pediatr Gastroenterol Nutr 2012; 54: 374-380
• 2 Mowat C, Cole A, Windsor A et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011; 60: 571-607
• 3 Turner D, Levine A, Escher JC et al. Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr 2012; 55: 340-361
• 4 Kane S. Endoscopic healing should be a goal for everyone with ulcerative colitis. Inflamm Bowel Dis 2008;
• 5 Lichtenstein GR, Rutgeerts P. Importance of mucosal healing in ulcerative colitis. Inflamm Bowel Dis 2010; 16: 338-346
• 6 de Chambrun GP, Peyrin-Biroulet L, Lemann M et al. Clinical implications of mucosal healing for the management of IBD. Nat Rev Gastroenterol Hepatol 2010; 7: 15-29
• 7 Sandborn WJ. Current directions in IBD therapy: what goals are feasible with biological modifiers?. Gastroenterology 2008; 135: 1442-1447
• 8 Schoofs N, Deviere J, Van Gossum A et al. PillCam colon capsule endoscopy compared with colonoscopy for colorectal tumor diagnosis: a prospective pilot study. Endoscopy 2006; 38: 971-977
• 9 Van Gossum A, Navas MM, Fernandez-Urien I et al. Capsule endoscopy versus colonoscopy for the detection of polyps and cancer. N Engl J Med 2009; 361: 264-270
• 10 Eliakim R, Yassin K, Niv Y et al. Prospective multicenter performance evaluation of the second-generation colon capsule compared with colonoscopy. Endoscopy 2009; 41: 1026-1031
• 11 Spada C, Hassan C, Munoz-Navas M et al. Second-generation colon capsule compared with colonoscopy. Gastrointest Endosc 2011; 74: 581-589 Erratum in Gastrointest Endosc 2011; 74: 1174
• 12 Spada C, Hassan C, Galmiche JP et al. Colon capsule endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 2012; 44: 527-536
• 13 Sung J, Ho KY, Chiu HM et al. The use of Pillcam Colon in assessing mucosal inflammation in ulcerative colitis: a multicenter study. Endoscopy 2012; 44: 754-758
• 14 Ye CA, Gao YJ, Ge ZZ et al. PillCam colon capsule endoscopy versus conventional colonoscopy for the detection of severity and extent of ulcerative colitis. J Dig Dis 2013; 14: 117-124
• 15 Meister T, Heinzow HS, Domagk D et al. Colon capsule endoscopy versus standard colonoscopy in assessing disease activity of ulcerative colitis: a prospective trial. Tech Coloproctol 2013; 17: 641-646
• 16 Hosoe N, Matsuoka K, Naganuma M et al. Applicability of second generation colon capsule endoscope to ulcerative colitis: a clinical feasibility study. J Gastroenterol Hepatol 2013; 28: 1174-1179
• 17 Turner D, Otley AR, Mack D et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology 2007; 133: 423-432
• 18 Turner D, Levine A, Hirsh A et al. Evidence-based recommendations for bowel cleansing before colonoscopy in children: a report from a national working group. Endoscopy 2010; 42: 1063-1070
• 19 Osada T, Ohkusa T, Yokoyama T et al. Comparison of several activity indices for the evaluation of endoscopic activity in UC: inter- and intraobserver consistency. Inflamm Bowel Dis 2010; 16: 192-197
• 20 Levine A, Griffiths A, Markowitz J et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011; 17: 1314-1321
• 21 Leighton JA, Rex DK. A grading scale to evaluate colon cleansing for the PillCam COLON capsule: a reliability study. Endoscopy 2011; 43: 123-127
• 22 McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 2012; 22: 276-282